← Back to Search

Intraocular Lens

Hoya AF-1 IOL for Cataract

Phase 4
Waitlist Available
Research Sponsored by Innovative Medical
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights

Summary

The doctors participating in this study are looking to show improved vision with the HOYA AF-1 aspheric intraocular lens after cataract surgery. They will also study the use of Revital Vision (neuro-sensory testing) in providing the highest potential for improved vision.

Eligible Conditions
  • Cataract

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Trial Design

2Treatment groups
Experimental Treatment
Group I: Revital VisionExperimental Treatment1 Intervention
Group II: Hoya AF-1 IOLExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Innovative MedicalLead Sponsor
51 Previous Clinical Trials
2,608 Total Patients Enrolled
14 Trials studying Cataract
572 Patients Enrolled for Cataract
~1 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top